Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance among Patients with Suspected Cardiac Sarcoidosis Is Associated with Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis

Circulation: Cardiovascular Imaging

Volumn 9, Issue 9, 2016, Pages

  Hulten, Edward ^a,b   Agarwal, Vikram ^a   Cahill, Michael ^b   Cole, Geoff ^b   Vita, Tomas ^a   Parrish, Scott ^b   Bittencourt, Marcio Sommer ^b,c,d   Murthy, Venkatesh L ^e,f   Kwong, Raymond ^a   Di Carli, Marcelo F ^a   Blankstein, Ron ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^e Division of Cardiovascular Medicine   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

cardiac arrhythmia; cardiomyopathies; heart conduction system; magnetic resonance imaging; sarcoidosis

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY CONTROL; RETROSPECTIVE STUDY; RISK FACTOR; SARCOIDOSIS; SYSTEMATIC REVIEW; ARRHYTHMIAS, CARDIAC; CARDIAC MUSCLE; CARDIOMYOPATHY; CHI SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; HEART VENTRICLE FUNCTION; MALE; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ODDS RATIO; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SARCOIDOSIS; VENTRICULAR FUNCTION;

EID: 84988799177     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.116.005001     Document Type: Article

References (22)

1. Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R, Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther 2016 6 50 63. doi: 10.3978/j.issn.2223-3652.2015.12.13.
2. Blankstein R, Waller AH, Evaluation of Known or Suspected Cardiac Sarcoidosis. Circ Cardiovasc Imaging 2016 9 e000867. doi: 10.1161/CIRCIMAGING.113.000867.
3. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ, Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005 45 1683 1690. doi: 10.1016/j.jacc.2005.01.047.
4. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ, Detection of myocardial damage in patients with sarcoidosis. Circulation 2009 120 1969 1977. doi: 10.1161/CIRCULATIONAHA.109.851352.
5. Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, Yu Z, Addetia K, Mor-Avi V, Moss JD, Hogarth DK, Sweiss NJ, Lang RM, Patel AR, Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance. Circ Cardiovasc Imaging 2016 9 e003738. doi: 10.1161/CIRCIMAGING.115.003738.
6. Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H, CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013 6 501 511. doi: 10.1016/j.jcmg.2012.10.021.
7. Shafee MA, Fukuda K, Wakayama Y, Nakano M, Kondo M, Hasebe Y, Kawana A, Shimokawa H, Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis. J Cardiol 2012 60 448 453. doi: 10.1016/j.jjcc.2012.08.002.
8. Nadel J, Lancefield T, Voskoboinik A, Taylor AJ, Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Eur Heart J Cardiovasc Imaging 2015 16 634 641. doi: 10.1093/ehjci/jeu294.
9. Crawford T, Mueller G, Sarsam S, Prasitdumrong H, Chaiyen N, Gu X, Schuller J, Kron J, Nour KA, Cheng A, Ji SY, Feinstein S, Gupta S, Ilg K, Sinno M, Abu-Hashish S, Al-Mallah M, Sauer WH, Ellenbogen K, Morady F, Bogun F, Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol 2014 7 1109 1115. doi: 10.1161/CIRCEP.113.000156.
10. Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, Fukuda K, Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation. Chest 2014 146 1064 1072. doi: 10.1378/chest.14-0139.
11. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel AR, Sweiss NJ, Nguyen DT, Aleong RG, Varosy PD, Weinberger HD, Sauer WH, Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2012 23 925 929. doi: 10.1111/j.1540-8167.2012.02350.x.
12. Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC, Cooper JM, Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012 9 884 891. doi: 10.1016/j.hrthm.2012.02.010.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009 151 264 9, W64
14. Higgins JP, Thompson SG, Quantifying heterogeneity in a meta-analysis. Stat Med 2002 21 1539 1558. doi: 10.1002/sim.1186.
15. Harbord RM, Egger M, Sterne JA, A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006 25 3443 3457. doi: 10.1002/sim.2380.
16. Beaule PE, Shea B, Abedlbary H, Ahmadzai N, Skidmore B, Mallick R, Hutton B, Bunting AC, Moran J, Ward R, Moher D, A protocol for a systematic review of the diagnostic accuracy of blood markers, synovial fluid, and tissue testing in periprosthetic joint infections (PJI). Syst Rev 2015 4 148. doi: 10.1186/s13643-015-0124-1.
17. Hiraga H, Yuwai K, Hiroe M, Guidelines For Diagnosis Of Cardiac Sarcoidosis: Study Report On Diffuse Pulmonary Diseases 1993 Tokyo, Japan The Japanese Ministry Of Health And Welfare Tokyo 23 24
18. Hiraga H, Yuwai K, Hiroe M, Diagnostic standard and guidelines for sarcoidosis. Jpn J. Sarcoidosis and Granulomatous Disorders 2007 27 89 102
19. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Cheriex EC, Gorgels AP, Crijns HJ, The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005 128 1629 1637. doi: 10.1378/chest.128.3.1629.
20. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF, Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014 63 329 336. doi: 10.1016/j.jacc.2013.09.022.
21. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K, HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014 11 1305 1323. doi: 10.1016/j.hrthm.2014.03.043.
22. 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014 21 166 174. doi: 10.1007/s12350-013-9828-6.